Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Bromazepam presents significant abuse potential, reportedly greater than other benzodiazepines due to its fast absorption and rapid onset of action. Compulsive redosing is documented, and rebound anxiety following use can perpetuate cycles of dependence.
Physical dependence can develop within one to six months of continuous use, with up to 30% of long-term users developing dependence. Abrupt withdrawal after chronic use, even at therapeutic doses, can lead to severe withdrawal syndrome including status epilepticus and symptoms resembling delirium tremens. Withdrawal symptoms include anxiety, insomnia, tremor, sweating, nausea, seizures, hallucinations, and hyperthermia.
The acute toxic dose has been estimated at 180mg oral for an adult without tolerance or combination with other substances. However, consumption alone is very seldom fatal in healthy adults, as benzodiazepines act as positive modulators rather than direct agonists, conferring reduced overdose potential compared to barbiturates. Fatal overdose risk increases substantially when combined with other CNS depressants.
Liver damage of the cholestatic type, with or without jaundice, has been reported; the manufacturer recommends regular laboratory examinations for patients on long-term therapy.
Leukopenia has been observed in some patients during treatment.
Chronic use commonly causes impairments to memory functions including reduced working memory and reduced ability to process environmental information; long-term use may also cause mood swings, depression, depersonalization, and perceptual disturbances.
Paradoxical reactions including violent behavior, loss of impulse control, and suicidal behavior occur rarely, with an incidence rate below 1% in the general population. These reactions occur more frequently in recreational abusers, individuals with mental disorders, children, and patients on high-dosage regimens. Withdrawal may produce hallucinations and delirium in severe cases.
Paradoxical increased seizures in epileptics are rare during use. However, abrupt withdrawal after chronic use poses significant seizure risk, including potential for status epilepticus. Gradual dose reduction eliminates withdrawal-related seizure risk.
Bromazepam was developed by the Swiss pharmaceutical company Roche, receiving its patent in 1961. The compound was subsequently approved for medical use in 1974, entering the pharmaceutical market as an intermediate-acting anxiolytic medication.…
UN Convention on Psychotropic Substances 1971 (Schedule IV)
Controlled under the Controlled Drugs and Substances Act. All benzodiazepines, including bromazepam, are regulated as Schedule IV substances requiring a prescription.
Available by prescription only. Marketed under brand names including Bromazanil (Hexal). Not classified under Anlage listings of the Betäubungsmittelgesetz but regulated as a prescription-only medication.
Controlled under the Controlled Substances Act as a Schedule IV depressant. Illegal to sell without a license and illegal to possess without a valid license or prescription.
Regulated as a prescription medication. Available only through licensed pharmacies with valid medical authorization.
Scheduled on List II of the Opium Law. Preparation, possession, delivery, providing, and transport without authorization are prohibited. However, possession of small quantities for personal use is typically not prosecuted, and recreational use itself is not prohibited under Dutch law.
8 sources cited